877463-63-3

Basic information

• Product Name: (5S)-3-benzyloxymethyl-5-[(1R)-1,2-O-cyclohexylidene-1,2-dihydroxyethyl]-2-isoxazoline
• Synonyms: (5S)-3-benzyloxymethyl-5-[(1R)-1,2-O-cyclohexylidene-1,2-dihydroxyethyl]-2-isoxazoline
• CAS NO: 877463-63-3
• Molecular Weight: 331.412
• Mol File: 877463-63-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (5S)-3-benzyloxymethyl-5-[(1R)-1,2-O-cyclohexylidene-1,2-dihydroxyethyl]-2-isoxazoline(CAS DataBase Reference)
• NIST Chemistry Reference: (5S)-3-benzyloxymethyl-5-[(1R)-1,2-O-cyclohexylidene-1,2-dihydroxyethyl]-2-isoxazoline(877463-63-3)
• EPA Substance Registry System: (5S)-3-benzyloxymethyl-5-[(1R)-1,2-O-cyclohexylidene-1,2-dihydroxyethyl]-2-isoxazoline(877463-63-3)

Safety Data

• Hazardous Substances Data: 877463-63-3(Hazardous Substances Data)

Upstream product

• 87976-52-1 ((2-nitroethoxy)methyl)benzene 
• 135029-56-0 (2S)-1,2-O-cyclohexylidenebut-3-ene-1,2-diol 

Downstream Products

• 877463-75-7 (2R,3S)-1,3-O-benzylidene-1,3-dihydroxy-4-[(2S,4S,5R)-2-benzyloxymethyl-4,5-dihydroxypiperidinium-1-yl]butane-2-sulfate 
• 877463-76-8 (2S,3R)-1,3-dihydroxy-1,3-O-isopropylidene-4-[(2S,4S,5R)-2-benzyloxymethyl-4,5-dihydroxypiperidinium-1-yl]butane-2-sulfate 
• 877463-69-9 (2S,4S,5R)-3-benzyloxymethyl-4-hydroxypiperidinium 5-sulfate 
• 877463-67-7 (5S)-3-benzyloxymethyl-5-[(4R)-2,2-dioxo-1,3,2-dioxathiolan-4-yl]-2-isoxazoline 
• 877463-65-5 (5S)-3-benzyloxymethyl-5-[(4R)-2-oxo-1,3,2-dioxathiolan-4-yl]-2-isoxazoline 
• 877463-71-3 (2S,4S,5R)-3-benzyloxymethyl-4,5-dihydroxypiperidine 
• 334999-16-5 (5S)-5-[(1R)-1,2-dihydroxyethyl]-3-benzyloxymethyl-4,5-dihydrooxazole 

Relevant articles and documents

Synthesis of new nitrogen analogues of salacinol and deoxynojirimycin and their evaluation as glycosidase inhibitors

The synthesis of two enantiomerically pure iminosugars, analogues of 1-L-deoxynojirimycin (L-DNJ) and 1-D-deoxymannojirimycin (DMJ), was achieved using cyclic sulfate substituted isoxazoline derivatives. The piperidine ring was formed via the reduction of